ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY

Welcome to the Brand page for “ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY”, which is offered here for Medical and scientific research, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use;.

Its status is currently believed to be active. Its class is unavailable. “ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY” is believed to be currently owned by “BRISTOL-MYERS SQUIBB COMPANY”.